NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

Richard A. Kenley, PhD

Practice Area Focus

  • Drugs
  • Biologics
  • CMC
  • Manufacturing QA
  • Regulatory Strategy


Dr. Richard Kenley joined NDA Partners as an Expert Consultant in 2017. His accomplished career as an entrepreneur and senior business executive includes former President and CEO of Eurofins Advantar Laboratories; COO at Anaborex; President of Pharmaceutical Development Business Unit of Cardinal Health; Senior VP and General Manager of the San Diego Facility of Magellan (acquired by Cardinal Health); and Founder and General Manager of Cabrillo Laboratories (acquired by Magellan). He is a recognized industry leader with experience in R&D, start-up and in multinational corporate environments with expertise in small molecule and protein therapeutics, drug delivery systems and manufacturing.

In his early career, Dr. Kenley was Senior VP of Product Development at Amylin Pharmaceuticals; Director of Pharmaceutical Sciences, Genetics Institute; Associate Director of Chemistry R&D, Baxter Healthcare Corp.; Department Head, Pharmaceutical Analysis, Syntex Research; and Section Head, Medical Chemistry, Stanford Research Institute, International.

He is a Fellow of the American Academy of Pharmaceutical Scientists, has four patents, and more than 60 peer-reviewed research publications.